Potassium Chloride In Dextrose And Sodium Chloride Injection, Solution
NDC Package 65219-151-75
Package Information
Potassium Chloride In Dextrose And Sodium Chloride (dextrose monohydrate, sodium chloride, and potassium chloride) injection is these solutions are indicated in patients requiring parenteral administration of potassium chloride with minimal carbohydrate calories and sodium chloride. This formulation utilizes a injection, solution delivery system. Marketed by Fresenius Kabi Usa, Llc, this product is identified by NDC 65219-151 and is authorized under FDA application ANDA212348.
Identification & Billing
- RxCUI: 1863973 - potassium chloride 20 MEQ / dextrose 5 % / sodium chloride 0.225 % in 1000 ML Injection
- RxCUI: 1863973 - 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 2.25 MG/ML Injection
- RxCUI: 1863973 - 1000 ML Glucose 50 MG/ML / K+ Chloride 0.02 MEQ/ML / NaCl 2.25 MG/ML Injection
- RxCUI: 1863973 - 1000 ML Glucose 50 MG/ML / Pot Chloride 0.02 MEQ/ML / NaCl 2.25 MG/ML Injection
- RxCUI: 1863973 - potassium chloride 20 MEQ / dextrose 5 % / sodium chloride 0.225 % per 1000 ML Injection
Clinical Specifications
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Potassium Compounds - [CS]
- Potassium Salt - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 65219 - Fresenius Kabi Usa, Llc
- 65219-151 - Potassium Chloride In Dextrose And Sodium Chloride
- 65219-151-75 - 20 BAG in 1 CASE / 500 mL in 1 BAG (65219-151-00)
- 65219-151 - Potassium Chloride In Dextrose And Sodium Chloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 65219-151-75 identifies a specific commercial package of 20 bag in 1 case / 500 ml in 1 bag (65219-151-00) of Potassium Chloride In Dextrose And Sodium Chloride, a human prescription drug labeled by Fresenius Kabi Usa, Llc. This injection, solution is formulated for intravenous use and contains dextrose monohydrate; potassium chloride; sodium chloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Fresenius Kabi Usa, Llc on September 02, 2022. The current certification is valid through December 31, 2026.
How is this Fresenius Kabi Usa, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 65219015175. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.